Clinical Trials Directory

Trials / Completed

CompletedNCT04348786

Comparing Efficacy of 14-day Therapy Doxycycline With Bismuth Subsalicylate Versus Levofloxacin With Tinadizole on Treatment Helicobacter Pylori

Comparing the Efficacy of 14-day Therapy Doxycycline With Bismuth Subsalicylate Versus Levofloxacin With Tinidazole on Rate of Eradication of Helicobacter Pylori Infected Patients on Syrian Population

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
78 (actual)
Sponsor
Damascus Hospital · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

Comparison Efficacy of 10-days Therapy with Doxycycline with Bismuth Subsalicylate Versus Levofloxacine with Tinadizole on Eradication of Helicobacter Pylori in Syrian population.

Conditions

Interventions

TypeNameDescription
DRUGDoxycyclineDoxycylcine 100 mg bid ,esomprazole 20 bid,Bismuth subsalicylate 262 tab.2 tab q.i.d,Tinadizole 500 bid
DRUGLevofloxacin 500mgLevofloxacin 500 mg qd, amoxicillin 500 2cab bid,Tinadizole 500 bid, esomprazole 20 bid

Timeline

Start date
2019-02-01
Primary completion
2020-08-30
Completion
2020-09-01
First posted
2020-04-16
Last updated
2020-09-16

Locations

1 site across 1 country: Syria

Source: ClinicalTrials.gov record NCT04348786. Inclusion in this directory is not an endorsement.

Comparing Efficacy of 14-day Therapy Doxycycline With Bismuth Subsalicylate Versus Levofloxacin With Tinadizole on Treat (NCT04348786) · Clinical Trials Directory